FDA 483 - James W. Findling, M.D. - August 26, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of James W. Findling, M.D. in Milwaukee, WI, a clinical investigator, revealed a significant failure in ensuring proper Institutional Review Board (IRB) oversight. The study site failed to submit a revised protocol, which included additional subject safety assessments, for IRB review and approval, resulting in subjects continuing the study under an outdated protocol. This indicates a serious lapse in regulatory compliance regarding clinical study management and subject protection.
ID · 3d72d0b8-066b-4677-bb71-038521dc471b